EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Identification of a Duplication in the RP17 Locus in an Individual With Pathogenic CEP290 Variants: Implications for RP17 Variant Classification

Lara K Holtes, Di Chen, Siobhan Guilfoyle, Harriet O'Leary, Julio C Corral-Serrano, Erica G M Boonen, Lonneke Haer-Wigman, Sara E Nieuwenhuis, Rosellina Guarascio, Vasileios Toulis, Danilo Andrade de Jesus, Frans P M Cremers und 5 weitere

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.10.1 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Lara K Holtes und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Antigens, Neoplasm, Cell Cycle Proteins, Centrosomal Associated Proteins, Cone Dystrophy. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess the pathogenicity of a novel duplication in the RP17 locus identified in a cone dystrophy proband with biallelic CEP290 variants. Structural variants (SVs) in this locus have previously been associated with dominant retinitis pigmentosa.

Methods

Inheritance of the duplication was assessed by breakpoint polymerase chain reaction (PCR). Ophthalmic evaluation included fundus examination, multimodal retinal imaging, and full-field electroretinogram (ERG). A proband-derived pluripotent stem cell line was differentiated into photoreceptor precursor cells (PPCs) and retinal organoids (ROs). Variant-induced mis-splicing of CEP290 was assessed by reverse-transcription PCR (RT-PCR) and long-read cDNA sequencing, and immunohistochemistry was used to assess photoreceptor morphology. Expression of GDPD1 was quantified by quantitative RT-PCR.

Results

The proband and father carried the 324-kb duplication in the RP17 locus. The father was clinically unaffected, but the proband showed features of cone dystrophy, including reduced visual acuity, foveal abnormalities, diminished cone density, and preserved dark-adapted but absent light-adapted ERG responses. The compound heterozygous variants in CEP290 resulted in pseudoexon inclusion and exon 36 skipping in patient-derived retinal cells. Immunohistochemistry revealed altered ciliation and reduced trafficking of L/M opsin and rhodopsin in ROs. In silico modeling predicted that the novel RP17 duplication does not disrupt chromatin looping, and GDPD1 expression was not upregulated in patient ROs, in contrast to pathogenic RP17-SVs.

Conclusions

The cone dystrophy phenotype of the proband can be attributed to the CEP290 variants, whereas the novel RP17 duplication can be classified as likely benign based on the integrated evidence. These findings emphasize the importance of modeling and functional studies for accurately classifying RP17-SVs and preventing misinterpretation in clinical diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, NeoplasmCell Cycle ProteinsCentrosomal Associated ProteinsCone DystrophyCytoskeletal ProteinsGene DuplicationRetinitis PigmentosaFemaleHumansMaleDNA Mutational AnalysisElectroretinographyImmunohistochemistryPedigreeYoung AdultMiddle Aged

Substanzen

Antigens, NeoplasmCell Cycle ProteinsCentrosomal Associated ProteinsCep290 protein, humanCytoskeletal Proteins

Autor:innen und Institutionen

  • Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Institute of Ophthalmology, University College London, London, United Kingdom.
  • The Rotterdam Eye Hospital, Rotterdam Ophthalmic Institute, Rotterdam, the Netherlands.
  • Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Departament de Genètica, Microbiologia i Estadística, Universitat de Barcelona, Barcelona, Spain.
  • Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands.
  • Department of Ophthalmology, Erasmus MC, Rotterdam, the Netherlands.

Förderung

  • Wellcome Trust

Zitieren

APA

Holtes, L. K., Chen, D., Guilfoyle, S., O'Leary, H., Corral-Serrano, J. C., Boonen, E. G. M., Haer-Wigman, L., Nieuwenhuis, S. E., Guarascio, R., Toulis, V., Andrade de Jesus, D., Cremers, F. P. M., Thiadens, A. A. H. J., Cheetham, M. E., de Bruijn, S. E., Hardcastle, A. J., & Roosing, S. (2026). Identification of a Duplication in the RP17 Locus in an Individual With Pathogenic CEP290 Variants: Implications for RP17 Variant Classification. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.10.1

Vancouver

Holtes LK, Chen D, Guilfoyle S, O'Leary H, Corral-Serrano JC, Boonen EGM, et al. Identification of a Duplication in the RP17 Locus in an Individual With Pathogenic CEP290 Variants: Implications for RP17 Variant Classification. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.10.1

BibTeX
@article{Holtes2026,
  author = {Holtes, Lara K and Chen, Di and Guilfoyle, Siobhan and O'Leary, Harriet and Corral-Serrano, Julio C and Boonen, Erica G M and Haer-Wigman, Lonneke and Nieuwenhuis, Sara E and Guarascio, Rosellina and Toulis, Vasileios and Andrade de Jesus, Danilo and Cremers, Frans P M and Thiadens, Alberta A H J and Cheetham, Michael E and de Bruijn, Suzanne E and Hardcastle, Alison J and Roosing, Susanne},
  title = {Identification of a Duplication in the RP17 Locus in an Individual With Pathogenic CEP290 Variants: Implications for RP17 Variant Classification},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.10.1}
}
Kostenlos starten →